Uptick Partners LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 5,834 shares of the company’s stock, valued at approximately $750,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Gables Capital Management Inc. bought a new position in Merck KGaA in the 2nd quarter valued at $2,095,000. Diversify Advisory Services LLC bought a new position in shares of Merck KGaA in the second quarter worth $3,810,000. Danske Bank A S bought a new position in shares of Merck KGaA in the second quarter worth $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in shares of Merck KGaA in the second quarter worth $25,541,000. Finally, BOK Financial Private Wealth Inc. bought a new stake in Merck KGaA during the second quarter valued at $523,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Price Performance
Merck KGaA stock opened at $167.38 on Thursday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The business has a 50-day simple moving average of $162.50 and a 200 day simple moving average of $148.28. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market cap of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
